ScholarIQanswers from OpenAlex

Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism

PaperCitations, authors & open-access status

Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism have?

ScholarIQcitation count

Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism has 286 citations in the OpenAlex counts ScholarIQ stores.

When was Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism published?

ScholarIQyear

Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism has 1999 year in the ScholarIQ index.

What is the open-access status of Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism?

ScholarIQoa status

Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism has closed oa status in the ScholarIQ index.

What is the DOI of Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism?

ScholarIQdoi

The DOI for Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism is on the source record.

What is the PMID of Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism?

ScholarIQpmid

The PMID for Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism is on the source record.

What is the OpenAlex record for Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism?

ScholarIQopenalex

The OpenAlex for Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial